Sodium-Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia : A Population-Based Cohort Study. Journal Abstract

Sodium-Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia : A Population-Based Cohort Study.

Publication Date: 2024 Oct

Full Text Sources

Atypon

Ovid Technologies, Inc.

Authors

Bin Hong; Sungho Bea; Hwa Yeon Ko; Woo Jung Kim; Young Min Cho; Ju-Young Shin

Abstract

OBJECTIVE

Both sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have neuroprotective effects in patients with type 2 diabetes (T2D). However, their comparative effectiveness in preventing dementia remains uncertain.

Source

Annals of internal medicine

Pub Types(s)

Journal Article

Language

English

PubMed ID

39186787